Clinical impact of the CONUT score in patients with multiple myeloma
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical impact of the CONUT score in patients with multiple myeloma
Authors
Keywords
-
Journal
ANNALS OF HEMATOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-11-25
DOI
10.1007/s00277-019-03844-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The prognostic impact of pretransplant inflammatory and nutritional status in adult patients after myeloablative single cord blood transplantation
- (2019) Eita Miyashita et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Clinical impact of the CONUT score and mogamulizumab in adult T cell leukemia/lymphoma
- (2018) Hiroshi Ureshino et al. ANNALS OF HEMATOLOGY
- Clinical impact of prognostic nutritional index in diffuse large B cell lymphoma
- (2018) Se-Il Go et al. ANNALS OF HEMATOLOGY
- The pretreatment Controlling Nutritional Status (CONUT) score is an independent prognostic factor in patients with resectable thoracic esophageal squamous cell carcinoma: results from a retrospective study
- (2016) Takahiro Toyokawa et al. BMC CANCER
- Multiple Myeloma: Diagnosis and Treatment
- (2016) S. Vincent Rajkumar et al. MAYO CLINIC PROCEEDINGS
- Daratumumab, Lenalidomide, and Dexamethasone for Multiple Myeloma
- (2016) Meletios A. Dimopoulos et al. NEW ENGLAND JOURNAL OF MEDICINE
- Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report
- (2015) A. Palumbo et al. BLOOD
- Clinical course and prognosis of non-secretory multiple myeloma
- (2015) Sagar S. Chawla et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
- (2015) Antonio Palumbo et al. JOURNAL OF CLINICAL ONCOLOGY
- Elotuzumab Therapy for Relapsed or Refractory Multiple Myeloma
- (2015) Sagar Lonial et al. NEW ENGLAND JOURNAL OF MEDICINE
- Impact of the Preoperative Controlling Nutritional Status (CONUT) Score on the Survival after Curative Surgery for Colorectal Cancer
- (2015) Yasuhito Iseki et al. PLoS One
- Panobinostat plus bortezomib and dexamethasone versus placebo plus bortezomib and dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma: a multicentre, randomised, double-blind phase 3 trial
- (2014) Jesús F San-Miguel et al. LANCET ONCOLOGY
- Light chain multiple myeloma, clinic features, responses to therapy and survival in a long-term study
- (2014) Jia-jia Zhang et al. World Journal of Surgical Oncology
- IMWG consensus on risk stratification in multiple myeloma
- (2013) W J Chng et al. LEUKEMIA
- Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics
- (2012) Y Kanda BONE MARROW TRANSPLANTATION
- IgD multiple myeloma a descriptive report of 17 cases: survival and response to therapy
- (2012) Francesco Pisani et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Continuous Lenalidomide Treatment for Newly Diagnosed Multiple Myeloma
- (2012) Antonio Palumbo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Thalidomide for previously untreated elderly patients with multiple myeloma: meta-analysis of 1685 individual patient data from 6 randomized clinical trials
- (2011) P. M. Fayers et al. BLOOD
- Bortezomib plus Melphalan and Prednisone for Initial Treatment of Multiple Myeloma
- (2008) Jesús F. San Miguel et al. NEW ENGLAND JOURNAL OF MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now